Xiaomo Wang
Beijing Municipal Education Commission And Beijing Key Laboratory Of Nasal Diseases
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Pollen-Pharmacotherapy Interaction Impacts Symptom Control in Seasonal Allergic Rhinitis.
Journal: Allergy
Published: February 10, 2026
Lower Airway Conditions Contribute to the Prediction of Polyp Recurrence in Chronic Rhinosinusitis With Nasal Polyps and Comorbid Asthma.
Journal: International forum of allergy & rhinology
Published: January 08, 2026
Association of non-alcoholic fatty liver polygenic risk scores with the incident and progressive non-alcoholic fatty liver disease in Chinese population.
Journal: Genes & nutrition
Published: May 02, 2025
Estimated cost-effectiveness of early screening strategies for newborn hearing impairment using a Markov model.
Journal: Frontiers in public health
Published: September 19, 2024
Statin Use and Development and Progression of Nonalcoholic Fatty Liver Disease Based on Ultrasonography.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 15, 2024
Effect of cumulative body mass index exposure and long-term related change on incident non-alcoholic fatty liver disease.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 18, 2022
Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China.
Journal: Hepatobiliary surgery and nutrition
Published: December 19, 2021
Short-term weight loss decreased the risk of chronic kidney disease in men with incident nonalcoholic fatty liver disease.
Journal: Obesity (Silver Spring, Md.)
Published: November 23, 2021
Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir.
Journal: Expert review of gastroenterology & hepatology
Published: September 13, 2021
Entecavir combined with interferon-α Is superior to entecavir monotherapy in reducing hepatic and extrahepatic cancer in patients with chronic hepatitis B.
Journal: Cancer
Published: July 13, 2021
Last Updated: 09/26/2026